News
KG., Knf Neuberger, Inc., The leading players of Intra-Aortic Balloon Pump (IABP) industry, their market share, product portfolio, company profiles are covered in this report. The leading market ...
The IABP, developed in the 1960s, was the first device to provide temporary mechanical support to the heart in patients with cardiogenic shock, Sacco said. Although other such devices have been ...
Hosted on MSN1mon
Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transportemphasized the company’s dedication to supporting healthcare professionals in diverse settings. “With the AC3 Range™ IABP, we extend this commitment across care settings, serving patients ...
The AC3 Range™ IABP combines the simple interface and proprietary ... which may cause actual results or company actions to differ materially from what is expressed or implied by these statements.
August 30, 2011 (Paris, France) — The routine use of intra-aortic balloon pump (IABP) support during PCI for acute, potentially large anterior MIs--as measured by electrocardiography--does ...
The company says it “has received complaints involving the Cardiosave IABPs regarding ingress of fluids into the IABP affecting various electronic circuit boards,” including “one report of an adverse ...
For circulatory support in cardiogenic shock, the best choice between Impella and intra-aortic balloon pump (IABP) has been controversial. Now, new data is complicating the debate. Presenting at ...
Get Instant Summarized Text (Gist) Early use of an intra-aortic balloon pump (IABP) in patients with cardiogenic shock due to heart failure did not improve 60-day survival or facilitate transition ...
Leveraging the patented technology of the AC3 Optimus™ IABP, the AC3 Range™ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results